Home Privacy Archive Realtime Report

Stock Trading History of Linnik Matthew D

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Linnik Matthew D since year 2005. The trader's CIK number is 1237521. At the time of this reporting, Linnik Matthew D is the CSO & Exec VP of Research of La Jolla Pharmaceutical Co (stock ticker symbol LJPC).

Stock purchases, sales, and option exercises reported by *Linnik Matthew D* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2006-12-21	LJPC	La Jolla Pharmaceutical Co	Sale	5,000	2.88	14,394
2006-12-27	LJPC	La Jolla Pharmaceutical Co	Sale	365	3.03	1,105

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Linnik Matthew D (CSO & Exec VP of Research of La Jolla Pharmaceutical Co at the time of this reporting) see the Securities and Exchange Commission (SEC) website.